We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
2301
Prothena Corp
PRTA
$444M
– –
-42,173
Closed -$705K
PTGX icon
2302
Protagonist Therapeutics
PTGX
$8.73B
– –
-2,697
Closed -$121K
PTLO icon
2303
Portillo's
PTLO
$328M
– –
-5,797
Closed -$77K
PVBC
2304
DELISTED
Provident Bancorp
PVBC
$0 ﹤0.01%
26
– –
PYXS icon
2305
Pyxis Oncology
PYXS
$200M
– –
-369
Closed -$1K
QSR icon
2306
Restaurant Brands International
QSR
$25.6B
– –
-321
Closed -$23K
QURE icon
2307
uniQure
QURE
$3.03B
$0 ﹤0.01%
47
-13,483
-100% -$116K
RARE icon
2308
Ultragenyx Pharmaceutical
RARE
$2.54B
$0 ﹤0.01%
14
-18,700
-100% -$928K
RCKT icon
2309
Rocket Pharmaceuticals
RCKT
$376M
$0 ﹤0.01%
30
– –
RCMT icon
2310
RCM Technologies
RCMT
$204M
– –
-412
Closed -$8K
REX icon
2311
REX American Resources
REX
$1.46B
$0 ﹤0.01%
10
– –
RGLD icon
2312
Royal Gold
RGLD
$17.5B
$0 ﹤0.01%
+2
New +$289
RGNX icon
2313
Regenxbio
RGNX
$659M
$0 ﹤0.01%
45
-7,585
-99% -$71.2K
RGLS
2314
DELISTED
Regulus Therapeutics
RGLS
$0 ﹤0.01%
122
– –
RIG icon
2315
Transocean
RIG
$5.78B
– –
-34,888
Closed -$148K
RIVN icon
2316
Rivian
RIVN
$22.8B
– –
-66
Closed –
RJF icon
2317
Raymond James Financial
RJF
$34.3B
$0 ﹤0.01%
5
+4
+400% +$604
RKLB icon
2318
Rocket Lab Corp
RKLB
$46.5B
– –
-9,381
Closed -$91K
RLAY icon
2319
Relay Therapeutics
RLAY
$4.26B
– –
-818
Closed -$5K
RLJ icon
2320
RLJ Lodging Trust
RLJ
$1.89B
$0 ﹤0.01%
+25
New +$243
RPTX
2321
DELISTED
Repare Therapeutics
RPTX
– –
-594
Closed -$2K
RRX icon
2322
Regal Rexnord
RRX
$14.6B
– –
-1,862
Closed -$308K
RSVR
2323
Reservoir Media
RSVR
$662M
$0 ﹤0.01%
+91
New +$803
RUN icon
2324
Sunrun
RUN
$2.63B
– –
-3,855
Closed -$68K
RXT icon
2325
Rackspace Technology
RXT
$1.31B
– –
-96,776
Closed -$237K
91 92
93
94 95

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.